FDA Inspection 1211604 - AstraZeneca Pharmaceuticals LP - July 18, 2023
FDA Inspection 1211604 for AstraZeneca Pharmaceuticals LP on July 18, 2023. Classification: No Action Indicated (NAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1211604 for AstraZeneca Pharmaceuticals LP on July 18, 2023. Classification: No Action Indicated (NAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
July 18, 2023
Product Type
Drugs
ID: 0be927c9-c21d-435f-8245-0b0aae7ef5e6
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox